Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |